Narrative Exposure Therapy for Adults With an Intellectual Disability
- Conditions
- Trauma, PsychologicalLearning DisabilityPTSDIntellectual Disability, Mild
- Registration Number
- NCT06934109
- Lead Sponsor
- University of Nottingham
- Brief Summary
The goal of this naturalistic single case series design is to investigate if an adapted Narrative Exposure Therapy protocol can be effective, is feasible, and acceptable for adults with a mile learning disability.
Participants will be complete three baseline sessions before taking part in Narrative Exposure Therapy using a manual that has been adapted for people with a learning disability. Trauma symptoms will be measured weekly using the Impact of Events scale adapted for intellectual disabilities. The person's carer will also complete an informant scale related to these symptoms (LANTS-IV). The client will also complete the CORE-LD at pre, and post therapy. Six weeks after the end of the intervention, the client and their carer will be invited to a feedback session to talk about how they found the intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 12
- Age 18 and over
- Meet the criteria for having a mild ID as assessed by a clinical psychologist within the team
- English speaking
- Have capacity to consent
- The participant must be experiencing trauma related stress as assessed by themselves, the clinical psychologist and the research team
- Be able to travel to one of the therapy sites
- Carer participant must have ability to reflect and comment on the trauma related stress experienced by the client participant
- Carer must also be 18 years old or older and be English speaking.
- Carer must have known participant for 1 year or more.
- They are substance dependent
- They are currently receiving another trauma-focused intervention
- Currently an inpatient
- Carers excluded if they lack capacity to consent to take part in research
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Impact of Events Scale for intellectual disabilities (IES-ID) Completed weekly through baseline and intervention stages, approximately 16 weeks. Then at 6-week follow up (approximately week 22). The IES-ID (Hall et al., 2014) is a 22 item scale scored on a three-point Likert scale measuring trauma related symptoms. This is an adapted measure that has been validated for people with an intellectual disability.
Lancaster and Northgate Trauma Scale for Intellectual Disabilities - Informant Version (LANTS-IV; Wigham et al., 2011) Completed weekly through baseline and intervention stages, approximately 16 weeks. Then at 6-week follow up (approximately week 22). 47 scored on a six-point scale for frequency and three-point for severity.
Clinical Outcome Routine Evaluation-Learning Disabilities (CORE-LD; Brooks et al., 2013) At baseline week 1 and at 6-week follow-up (approximately week 22). 14 scored on a three-point Likert scale measuring psychological distress across four domains: well-being, symptoms, functioning, and risk
Change interview (Elliott et al., 2001) with clients and carers 6-weeks post-intervention. Sessions will be around 30-60 minutes. A feedback session will be held with the client and their carer around 6-weeks after the therapy has come to an end. This will ask for feedback on how they found the intervention.
- Secondary Outcome Measures
Name Time Method Heart rate Weekly during the intervention sessions, for approximately 12-weeks. Heart rate will be taken using a fitness watch that can measure continuous heart rate. This will show whether any within and between session habituation has taken place. Subjective units of distress (Wolpe, 1969) will be used if clients do not wish to wear a heart rate device.
Post-session therapist reflections Across the intervention phase, an average of a year Therapist reflections will be collected to gather information about their thoughts relating to the manual and therapy.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Nottinghamshire Healthcare NHS Foundation Trust
🇬🇧Nottingham, United Kingdom